Home

Fészek ő az Függetlenül bcr abl kinase épít Probléma meghallgatás

Flying under the radar: the new wave of BCR–ABL inhibitors | Nature Reviews Drug Discovery
Flying under the radar: the new wave of BCR–ABL inhibitors | Nature Reviews Drug Discovery

Bcr-Abl tyrosine-kinase inhibitor - Wikipedia
Bcr-Abl tyrosine-kinase inhibitor - Wikipedia

IJMS | Free Full-Text | Blockade of Y177 and Nuclear Translocation of Bcr- Abl Inhibits Proliferation and Promotes Apoptosis in Chronic Myeloid Leukemia Cells
IJMS | Free Full-Text | Blockade of Y177 and Nuclear Translocation of Bcr- Abl Inhibits Proliferation and Promotes Apoptosis in Chronic Myeloid Leukemia Cells

Structure and Dynamic Regulation of Abl Kinases* - ScienceDirect
Structure and Dynamic Regulation of Abl Kinases* - ScienceDirect

Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia | Nature Reviews Cancer
Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia | Nature Reviews Cancer

Bcr-Abl阻害 | Bcr-Abl Inhibition
Bcr-Abl阻害 | Bcr-Abl Inhibition

Allosteric Inhibition of Bcr-Abl Kinase by High Affinity Monobody Inhibitors Directed to the Src Homology 2 (SH2)-Kinase Interface* - Journal of Biological Chemistry
Allosteric Inhibition of Bcr-Abl Kinase by High Affinity Monobody Inhibitors Directed to the Src Homology 2 (SH2)-Kinase Interface* - Journal of Biological Chemistry

Differential signaling networks of Bcr–Abl p210 and p190 kinases in leukemia cells defined by functional proteomics | Leukemia
Differential signaling networks of Bcr–Abl p210 and p190 kinases in leukemia cells defined by functional proteomics | Leukemia

Frontiers | The Discovery of Novel BCR-ABL Tyrosine Kinase Inhibitors Using a Pharmacophore Modeling and Virtual Screening Approach
Frontiers | The Discovery of Novel BCR-ABL Tyrosine Kinase Inhibitors Using a Pharmacophore Modeling and Virtual Screening Approach

Hematology Reports | Free Full-Text | Outcomes of the Pregnancies with Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era and Literature Review
Hematology Reports | Free Full-Text | Outcomes of the Pregnancies with Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era and Literature Review

Schematic representation of the mechanism of action of the BCR-ABLTKIs.... | Download Scientific Diagram
Schematic representation of the mechanism of action of the BCR-ABLTKIs.... | Download Scientific Diagram

Tyrosine-kinase inhibition in treatment of chronic myeloid leukaemia - The Lancet
Tyrosine-kinase inhibition in treatment of chronic myeloid leukaemia - The Lancet

BCR-ABL activates multiple downstream signaling pathways that... | Download Scientific Diagram
BCR-ABL activates multiple downstream signaling pathways that... | Download Scientific Diagram

The tyrosine kinase c-Abl potentiates interferon-mediated antiviral immunity by STAT1 phosphorylation - ScienceDirect
The tyrosine kinase c-Abl potentiates interferon-mediated antiviral immunity by STAT1 phosphorylation - ScienceDirect

Frontiers | Potential Approaches Versus Approved or Developing Chronic Myeloid Leukemia Therapy
Frontiers | Potential Approaches Versus Approved or Developing Chronic Myeloid Leukemia Therapy

Structure, Regulation, Signaling, and Targeting of Abl Kinases in Cancer - Oliver Hantschel, 2012
Structure, Regulation, Signaling, and Targeting of Abl Kinases in Cancer - Oliver Hantschel, 2012

A model for the regulation of BCR-ABL nuclear import through conformational interplay between the kinase domain, the FABD and the NLS region.
A model for the regulation of BCR-ABL nuclear import through conformational interplay between the kinase domain, the FABD and the NLS region.

Allosteric BCR-ABL inhibitors in Philadelphia chromosome-positive acute lymphoblastic leukemia: novel opportunities for drug combinations to overcome resistance | Haematologica
Allosteric BCR-ABL inhibitors in Philadelphia chromosome-positive acute lymphoblastic leukemia: novel opportunities for drug combinations to overcome resistance | Haematologica

Dasatinib is an Orally Active Dual Bcr-Abl and Src Family Tyrosine Kinase Inhibitor | MedChemExpress
Dasatinib is an Orally Active Dual Bcr-Abl and Src Family Tyrosine Kinase Inhibitor | MedChemExpress

JCI - Applying the discovery of the Philadelphia chromosome
JCI - Applying the discovery of the Philadelphia chromosome

Bcr-Abl and Imatinib (STI571 or Gleevec) - Proteopedia, life in 3D
Bcr-Abl and Imatinib (STI571 or Gleevec) - Proteopedia, life in 3D

PDF] Molecular Pathways Molecular Pathways : BCR-ABL | Semantic Scholar
PDF] Molecular Pathways Molecular Pathways : BCR-ABL | Semantic Scholar